Dulaglutide (~ 63,000 Da) is derived from two modified GLP-1 molecules attached to an Fc fragment of immunoglobulin G and has a half-life of ~ 5 days [22]
Notably, the Lp(a)HORIZON (NCT04023552), OCEAN(a) (NCT04606602) and ACCLAIM-Lp(a) (NCT05581303) trials are currently underway
However, maximum metabolic benefits occur when weight loss accompanies the direct medication effects
An exception existed during the period when semaglutide appeared on the FDA drug shortage list
Understanding these effects can empower patients to use Fluconazole safely and effectively
Lastly, the limited evidence on the effects of GLP-1 RAs on key pathognomonic proteins, A and -synuclein, weakens the scientific basis for considering GLP-1 RAs as major game-changers for neurodegenerative diseases